Drug Profile
Research programme: oxytocin antagonists - GlaxoSmithKline
Latest Information Update: 19 Apr 2011
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class
- Mechanism of Action Oxytocin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Preterm labour
Most Recent Events
- 02 Oct 2006 Preclinical trials in Preterm labour in United Kingdom (PO)